RDC 903/2024
Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.
RDC 903/2024 is ANVISA Collegiate Board Resolution 903/2024. A Collegiate Board Resolution is ANVISA’s primary binding regulation. The number is sequential within the year (RDC 751/2022 is resolution 751 issued in 2022).
- Instrument
- RDC
- Full name
- Resolução da Diretoria Colegiada
- Category
- Registration
- Source publication
- Portuguese
- Readable HTML
- 1 language version
- Published
- September 9, 2024
- Effective
- September 9, 2024
Open a language version
Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.
RDC 903/2024 — transfers and company-data changes
Complete eight-page official Espírito Santo health-secretariat hosted expression of ANVISA RDC 903/2024. It addresses corporate/commercial operations with unchanged technical-sanitary conditions; Article3 excludes unrelated corporate-name changes. The federal DOU publication controls. This source does not establish one route for every device/IVD change or later currentness.
A Collegiate Board Resolution is ANVISA’s primary binding regulation. The number is sequential within the year (RDC 751/2022 is resolution 751 issued in 2022). Always confirm the current consolidated text and transition provisions with the official source before filing.